Pharmacist Involvement at Discharge with the Joint Commission Heart Failure Core Measure: Challenges and Lessons Learned

Herring, Holly R.; Smith, W. L.; Ripley, Toni L.; Farmer, Kevin C.

doi:10.1310/hpj4911-1017

Cited by 1 publication

(1 citation statement)

References 2 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Pharmacists can review medication charts and make interventions such as medication reconciliation for discharged patients and correct medication discrepancies, dealing with barriers to medication documentation and interdisciplinary communication [20]. Pharmacist-led medication review and reconciliation were effective in improving medication adherence and patient outcomes, as well as in reducing hospitalization improving post-hospital medication safety and health care utilization [17,18].…”

Section: Introductionmentioning

confidence: 99%

Study protocol: systematic review and meta-analysis on the effectiveness of pharmacist intervention on health related quality of life and clinical outcomes among patients with heart failure

Tirfe

Beyene

Berhane

et al. 2020

Preprint

View full text Add to dashboard Cite

Background: Heart failure (HF) is associated with severe complications, hospitalization, and poor quality of life. Patients with heart failure had poor physical and emotional symptoms, functional status and worse health outcomes.Objective: The aim of this systematic review and meta-analysis will be to investigate whether pharmacist intervention is effective in improving health related quality of life (HRQoL) and clinical outcomes among patients with heart failure.Method: Systematic review and meta-analysis will be conducted. Published journals in English and indexed in Medline (PubMed), Embase, Cochrane Central Register of Controlled Trials (CENTRAL), Scopus, and Google scholar will be searched from 1990 to December 2019. Data will be extracted by one author and will be approved by other two authors independently. Data will be analyzed in accordance with the Cochrane handbook. Standardized mean differences will be used as an estimate of the effect size. Quality of included studies will be assessed using the modified Downs and Black checklist. Analysis for the dichotomous outcome studies will be converted into standardized mean difference and present with 95% confidence intervals. The review is approved in the International Prospective Register of Systematic Reviews (PROSPERO) with registration ID CRD42020158236.Discussion: Currently there are important gaps on the effectiveness of pharmacist intervention in improving health-related quality of life and clinical outcomes. We believe this review will provide comprehensive evidence on the effectiveness of pharmacist intervention among patients with HF.

show abstract

Section: Introductionmentioning

confidence: 99%

Study protocol: systematic review and meta-analysis on the effectiveness of pharmacist intervention on health related quality of life and clinical outcomes among patients with heart failure

Tirfe

Beyene

Berhane

et al. 2020

Preprint

View full text Add to dashboard Cite

show abstract

Pharmacist Involvement at Discharge with the Joint Commission Heart Failure Core Measure: Challenges and Lessons Learned

Abstract: Although pharmacist involvement at discharge did not translate into improved compliance with the HF core measure, systematic barriers to compliance were identified and are currently being addressed.

Cited by 1 publication

References 2 publications

Study protocol: systematic review and meta-analysis on the effectiveness of pharmacist intervention on health related quality of life and clinical outcomes among patients with heart failure

Study protocol: systematic review and meta-analysis on the effectiveness of pharmacist intervention on health related quality of life and clinical outcomes among patients with heart failure

Contact Info

Product

Resources

About